Literature DB >> 26039828

Nonalcoholic fatty liver disease in patients with coronary disease from a Brazil northeast area.

Consuêlo Padilha Vilar1, Helma Pinchemel Cotrim1, Gesira Soares Assis Florentino1, Gerson Bragagnoli1, Paulo Adriano Schwingel1, Cibelle Padilha Vilar Barreto2.   

Abstract

Background Nonalcoholic fatty liver disease (NAFLD) is the most frequent chronic liver injury around the world. It is associated with metabolic syndrome and cardiovascular diseases. Objective To evaluate the frequency and relevance of NAFLD in patients with coronary artery disease (CAD). Methods Patients from a Brazil Northeast area, who underwent elective coronary angiography (CAG) from 2009 to 2010 were included. All of them had suspicion of CAD. Criteria to CAD: presence of obstructive lesions in the epicardial coronary arteries, or in their major branches. NAFLD criteria: presence of hepatic steatosis on ultrasound; exclusion of other liver diseases; ethanol intake ≤ 20g/day. Statistics analysis included Independent t-test, Mann-Whitney and Pearson's chi-squared test. Multivariate regression analysis measured the relationship between the risk factors and the concomitant presence of CAD and NAFLD. Results A total of 244 patients were evaluated: 63.5% had CAD and 42.2% had NAFLD. NAFLD was observed in 43.9% of the CAD patients. The regression analysis showed that the relationship between CAD and NAFLD was positively correlated with HOMA-IR ≥3.0 or insulin resistance and overweight/obesity. Conclusion NAFLD was frequent among CAD patients; insulin resistance and overweight/obesity were the most relevant risk factors related to the association NAFLD and CAD. The results suggest that patients with CAD should be evaluated for NAFLD.

Entities:  

Mesh:

Year:  2015        PMID: 26039828     DOI: 10.1590/S0004-28032015000200007

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  5 in total

Review 1.  Prevalence of Cardioprotective Medication Use in Coronary Heart Disease Patients in South America: Systematic review and Meta-Analysis.

Authors:  A Marzà-Florensa; E Drotos; P Gulayin; D E Grobbee; V Irazola; K Klipstein-Grobusch; I Vaartjes
Journal:  Glob Heart       Date:  2022-06-08

2.  Association of Adiponectin Gene Polymorphisms With the Risk of Coronary Artery Disease in Patients With Nonalcoholic Fatty Liver Disease in a Chinese Han Population.

Authors:  Shui-Xian Du; Lin-Lin Lu; Yang Liu; Quan-Jiang Dong; Shi-Ying Xuan; Yong-Ning Xin
Journal:  Hepat Mon       Date:  2016-06-26       Impact factor: 0.660

Review 3.  Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review.

Authors:  Xiao-Lin Li; Jian-Qing Sui; Lin-Lin Lu; Nan-Nan Zhang; Xin Xu; Quan-Yong Dong; Yong-Ning Xin; Shi-Ying Xuan
Journal:  Lipids Health Dis       Date:  2016-03-10       Impact factor: 3.876

4.  Relationship between AGT rs2493132 polymorphism and the risk of coronary artery disease in patients with NAFLD in the Chinese Han population.

Authors:  Mengzhen Dong; Shousheng Liu; Mengke Wang; Yifen Wang; Yongning Xin; Shiying Xuan
Journal:  J Int Med Res       Date:  2021-07       Impact factor: 1.671

5.  AGTR1 rs3772622 gene polymorphism increase the risk of nonalcoholic fatty liver disease patients suffer coronary artery disease in Northern Chinese Han population.

Authors:  Yang Liu; Lin-Lin Lu; De-Xi Yuan; Ning Geng; Shi-Ying Xuan; Yong-Ning Xin
Journal:  Lipids Health Dis       Date:  2016-06-24       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.